Cite
MLA Citation
Stephen Hanauer et al.. “Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial.” Lancet gastroenterology and hepatology, vol. 6, 2021, pp. 816–825. http://access.bl.uk/ark:/81055/vdc_100144510246.0x000005